Compounds > 2'-cyano-2'-deoxyarabinofuranosylcytosine
Page last updated: 2024-09-03

2'-cyano-2'-deoxyarabinofuranosylcytosine and Acute Myelogenous Leukemia

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with Acute Myelogenous Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benaissa, S; Estrov, Z; Kantarjian, H; Liu, X; Matsuda, A; Plunkett, W; Wang, Y1
Azuma, A; Chubb, S; Guo, Y; Hittelman, W; Huang, P; Jiang, Y; Li, Y; Liu, X; Matsuda, A; Plunkett, W1
Azuma, A; Huang, P; Matsuda, A; Plunkett, W1

Other Studies

3 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and Acute Myelogenous Leukemia

ArticleYear
Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.
    Blood, 2010, Sep-09, Volume: 116, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Cell Line; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cytarabine; DNA Breaks, Double-Stranded; DNA Replication; DNA, Single-Stranded; Drug Resistance; Female; HCT116 Cells; HeLa Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recombination, Genetic; Sister Chromatid Exchange; Young Adult

2010
Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
    Cancer research, 2005, Aug-01, Volume: 65, Issue:15

    Topics: Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Checkpoint Kinase 1; Chromosome Aberrations; Cytarabine; DNA Damage; Drug Interactions; G2 Phase; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Mitosis; Protein Kinases; Signal Transduction; Staurosporine

2005
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.
    Molecular pharmacology, 2001, Volume: 59, Issue:4

    Topics: Antineoplastic Agents; CDC2 Protein Kinase; Chromosome Breakage; Cyclin B; Cyclin B1; Cytarabine; Deoxycytidine; DNA, Neoplasm; G2 Phase; Gemcitabine; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Phosphorylation; RNA; Tumor Cells, Cultured

2001